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Summary
The expression of galectin-3, a b-galactoside binding lectin, was found to be affected
by different kinds of stressors, and is strongly modified in numerous physiological and
pathophysiological conditions. Although no precise regulatory mechanisms of galectin-3
expression are unraveled, transcription factors AP-1 (activator protein 1) and NF-kB (nu-
clear factor kappa B) play an important role in these processes. Activities of both tran-
scription factors are affected by curcumin, a biologically active compound extracted from
rhizomes of Curcuma species. We have analyzed the impact of curcumin on the expression
of galectin-3 in glioblastoma cells under basal conditions and under stress invoked by the
cell exposure to alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and ul-
traviolet C (UV-C) light. Galectin-3 level was measured by western-blot technique using
M3/38 monoclonal antibody. Curcumin has decreased the basal level of galectin-3, while
the pretreatment of cells with curcumin has considerably reduced the inducible effect of
UV-C radiation and abolished the inducible effect of alkylating agent. Thus, curcumin has
been identified as a potent inhibitor of galectin-3 expression.
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Introduction
Galectin-3, a 32 kD lectin that specifically recognizes
b-galactoside structures of glycans, plays a pivotal role
in several biological processes (1) and its ubiquitous lo-
calization (in the nucleus and cytoplasm, on the cell
membrane and in the extracellular matrix) only con-
firms its diverse functions, including modulation of cell
adhesive properties (2–4) and regulation of cell motility
(5). Galectin-3 shows anti-apoptotic and growth-enhanc-
ing properties (6) and can promote cell invasiveness (7).
These abilities of galectin-3 are closely associated with
assets of tumorigenesis and metastasis (8–10) (e.g. ecto-
pic expression or inhibition of galectin-3 has been shown
either to increase or decrease tumorigenicity and meta-
static proclivity of tumor cells, respectively (11–13)). Re-
cently, elevation of galectin-3 level has become a useful
diagnostic marker for breast carcinoma (14), chordoma
(15), thyroid carcinoma (16) and some other tumors.
Curcumin 1,7-bis(4-hydroxy-3-methoxyphenyl)-
-1,6-heptadien-3,5-di-one is a natural, biologically active
compound extracted from rhizomes of Curcuma species
that gives the golden-yellow color and unique flavor to
curry. In Indian medicine it has been known for centu-
ries, while Western medicine discovered only lately its
anti-inflammatory, anti-oxidative, and cytostatic proper-
ties, as well as a potential to be used as a chemopre-
ventive agent in humans (17,18). It seems that mecha-
nisms underlying these effects involve suppression of
regulator(s) involved in activation of transcription fac-
tors c-Jun and NF-kB (nuclear factor kappa B) (19,20).
According to the results of our previous studies both of
these factors are involved in the regulation of the basal
expression of galectin-3 as well as of induced expression
of galectin-3 caused by alkylating agent N-methyl-N'-nitro-
N-nitrosoguanidine (MNNG) and ultraviolet C (UV-C)
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light (21). This is why both MNNG and UV-C light were
used as model stressors in this study of the ability of
curcumin to inhibit the expression of galectin-3.
Materials and Methods
Materials
All chemicals were of analytical grade and purcha-
sed from Sigma (St. Louis, MO, USA), if not stated oth-
erwise. Nitrocellulose membranes were purchased from
Millipore Corp. (Bedford, MA, USA), and heat-inactiva-
ted fetal calf serum (FCS) from Life Technologies (Rock-
ville, MD, USA). Rat monoclonal antibody M3/38 (anti-
galectin-3) was kindly provided by Dr. I. Rosenberg
(Harvard Medical School, Boston, MA). MNNG, anti-
mouse immunoglobulin G (IgG) labeled with alkaline
phosphatase, and anti-rat IgG labeled with alkaline
phosphatase were from Sigma (St Lewis, MO). Antibo-
dies against c-Jun were from Oncogene Research
Products (Cambridge, MA).
Cell lines, cell culture, and stress procedures
We have recently shown that human glioblastoma
A1235 cells undergo prompt glycosylation changes after
exposure to different stressors (22,21) and all experiments
described here were performed on this cell-line. Cells
were asynchronously grown (37 °C, 5 % CO2, relative
humidity 95 %) in the Dulbecco’s modified Eagle’s me-
dium (Sigma, Cat. No. D5648) supplemented with 10 %
heat-inactivated FCS, 100 mg/mL streptomycin and 100
U/mL penicillin. Cells were subcultured twice a week
to maintain cultures in exponential growth.
In all experiments cells were plated in tissue culture
dishes (60 ´ 15 mm) 24 h before treatment.
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Fig. 1. Effects of curcumin on basal and UV-C-induced expression of galectin-3.
A1235 glioblastoma cells were pre-incubated for 1 h in medium with or without curcumin (50mM), exposed or not to UV-C radiation (80
J/m2) and analyzed for galectin-3 (Gal-3) after 2, 4 and 24 h of further cultivation. Control cells were exposed neither to curcumin nor to
UV-C radiation.
A. Western blot analysis of galectin-3. Cellular proteins (10mg per lane) were separated by 12 % SDS-PAGE, transferred to Immobilon-P
membranes and analyzed with antibodies against galectin-3.
B. The amount of galectin-3 was estimated by densitometric analysis and expressed as normalized values relative to the level of galec-
tin-3 in the control cells. Average values (± standard deviation (SD)) from two independent series of experiments (analyzed in duplica-
tes) are shown.
* - p < 0.05 comparing to the controls, ** - p < 0.05 compared to the corresponding curcumin-untreated cells
To study the effects of UV-C light, cultivation me-
dium was removed and fresh medium (5 mL/culture)
was added. After 1 h the medium was removed and to
prevent the drying of the cells during irradiation, the
amount of fresh medium, which corresponds to 1 mm
high medium layer, was added (2.8 mL). Cells were ir-
radiated by Phillips UVT 15W/G15T T8 lamp with emis-
sion maximum at 254 nm. The intensity of irradiation
was determined using BioBlock VLX-3W dosimeter.
Control cell cultures were kept at the room temperature
during that time. After the exposure to the radiation
(10–15 s), all cell cultures were supplemented with re-
moved medium and returned into the incubator for the
next 2, 4 and 24 h.
For treatment with MNNG, cultivation medium was
removed and fresh medium (5 mL/culture) was added.
After 1 h, MNNG (5 mM) was added into medium. In
the control cell, MNNG was omitted. Cells were culti-
vated for the next 4 or 24 h under standard conditions.
To examine effects of curcumin on expression of
galectin-3 and c-Jun, cultivation medium was removed
and fresh medium containing 50 mM curcumin (5 mL/
culture) was added. In the control cell cultures fresh me-
dium without curcumin was added. Cells were cultiva-
ted for 1 h before adding MNNG, or exposure to UV-C
light, respectively.
Before analysis, cells were washed twice with ice-
-cold 0.137 mol/L NaCl, 2.7 mmol/L KCl, 4.3 mmol/L
Na2HPO4 × 7 H2O, 1.4 mmol/L KH2PO4, pH = 7.4 (PBS),
scraped and centrifuged at 600 ´ g for 10 min. The cell
pellet was lyzed in 1 % Triton X-100 in 5 mM Tris/HCl,
pH = 8.0, 15 mM NaCl, 2 % Na-azide, 2 mM phenyl-
methylsulfonyl fluoride (PMSF).
Western-blot analysis
Sodium dodecyl sulfate – polyacrylamide gel elec-
trophoresis (SDS-PAGE) was performed in 12 % poly-
acrylamide gels according to Laemmli (23). Separated
proteins were transferred onto nitrocellulose membrane
using semi-dry transfer technique. Membranes were
blocked overnight with 3 % bovine serum albumin
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Fig. 2. Effects of curcumin on basal and UV-C-induced expression of c-Jun.
A1235 glioblastoma cells were pre-incubated for 1 h in medium with or without curcumin (50mM), exposed or not to UV-C radiation (80
J/m2) and analyzed for c-Jun after 2, 4 and 24 h of further cultivation. Control cells were exposed neither to curcumin nor to UV-C radia-
tion.
A. Western blot analysis of c-Jun. Cellular proteins (10 mg per lane) were separated by 12 % SDS-PAGE, transferred to Immobilon-P
membranes and analyzed with antibodies against c-Jun.
B. The amount of c-Jun was estimated by densitometric analysis and expressed as normalized values relative to the level of c-Jun in the
control cells. Average values (±SD) from two independent series of experiments (analyzed in duplicates) are shown.
* - p < 0.05 compared to the controls, ** - p < 0.05 compared to the corresponding curcumin-untreated cells
(BSA) in 0.05 mol/L Tris/HCl, pH = 7.5, 0.15 mol/L
NaCl (TBS). Galectin-3 was identified with anti-galec-
tin-3 antibodies (culture supernatant from hibridoma
M3/38) diluted 1:50 in 3 % BSA in TBS. c-Jun was iden-
tified with polyclonal rabbit anti-Jun antibodies (1:1000
in 3 % BSA in TBS). After incubation with alkaline phos-
phatase-labeled secondary antibody (goat anti-rat IgG
diluted 1:2000 in TBS for galectin-3 and goat anti-rabbit
IgG diluted 1:1000 for c-Jun), proteins were visualized
with 0.02 g/L 5-bromo-4-chloro-3-indolyl phosphate
and 0.04 g/L nitro-blue tetrazolium in 0.05 mol/L Tris/
HCl, pH = 9.5, 0.1 mol/L NaCl, 0.005 mol/L MgCl2.
Membranes were incubated in dark until the color
developed (15 min on average) and digitalized with
UMAX Astra 610P Scanner using 300 ´ 300 dpi optical
resolution. Quantification of the bands corresponding to
galectin-3 or c-Jun was performed by two-dimensional
analysis (spot densitometry) in National Institute of Health
(NIH) software (»Tnimage Scientific Image Analysis
Software«, by T.J. Nelson). Single factor ANOVA was
used to measure statistical significance. Difference of p
< 0.05 was considered to be statistically significant.
Other procedures
Protein concentrations in cell homogenates were de-
termined by the method of Lowry (24).
Results
Effects of curcumin on basal
galectin-3 and c-Jun expression
Incubation of A1235 glioblastoma cells with curcu-
min (50 M) for 3 h did not result in statistically signifi-
cant change of galectin-3 level (Fig. 1, bar 5) or c-Jun
level (Fig. 2, bar 5). Additional 2 h-incubation resulted
in approximately 25 % decrease of galectin-3 level (Fig.
1, bar 6; Fig. 3, bar 3) as well as 20 % decrease of c-Jun
level (Fig. 2, bar 6, Fig. 4, bar 3). After prolonged incu-
bation (25 h) galectin-3 level remained in the reached
range (Fig. 1, bar 7; Fig. 3, bar 7) while c-Jun level fell
further, on approximately 65 % of the initial value (Fig.
2, bar 7; Fig. 4, bar 7).
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Fig. 3. Effects of curcumin on basal and MNNG-induced expression of galectin-3.
A1235 glioblastoma cells were pre-incubated for 1 h in medium with or without curcumin (50mM), MNNG was or was not added to the
medium (to the final concentration of 5 mM) and analyzed for galectin-3 (Gal-3) after 2, 4 and 24 h of further cultivation. Control cells
were exposed neither to curcumin nor to MNNG.
A. Western blot analysis of galectin-3. Cellular proteins (10mg per lane) were separated by 12 % SDS-PAGE, transferred to Immobilon-P
membranes and analyzed with antibodies against galectin-3.
B. The amount of galectin-3 was estimated by densitometric analysis and expressed as normalized values relative to the level of galec-
tin-3 in the control cells. Average values (±SD) from two independent series of experiments (analyzed in duplicates) are shown.
* - p < 0.05 compared to the controls; ** - p < 0.05 compared to the corresponding curcumin-untreated cells
Effects of curcumin on galectin-3 and c-Jun
expression in cells exposed to UV-C light
Cell exposure to UV-C radiation of 80 J/m2 has in-
duced expression of galectin-3. Two hours after irradia-
tion cell content of galectin-3 was approximately 60 %
higher compared to the initial values (Fig. 1, bar 2). Fur-
ther incubation was followed by additional elevation of
galectin-3 contents. After 4 and 24 h it reached levels
that were 70 % and 80 % higher than the initial one (Fig.
1, bars 3 and 4). At the same time c-Jun levels (2, 4 and
24 h), were found to be increased compared to the con-
trols by 3.7, 6.7 and 4.2 times, respectively (Fig. 2, bars 2,
3 and 4).
Cell pre-exposure to curcumin (50 mM) for 1 h cau-
sed considerable suppression of inducible effect of UV-C
radiation on galectin-3 expression. Galectin-3 levels in
the cells treated with curcumin for 1 h before UV-C ex-
posure were still elevated compared to the controls by
40, 38 and 26 % after 2, 4 and 24 h, respectively (Fig. 1,
bars 8, 9 and 10), but after 4 and 24 h they were signifi-
cantly lower compared to the corresponding curcumin-
-untreated cells by 20 and 30 %, respectively (Fig. 1, bar
8 vs. bar 2, bar 9 vs. bar 3, bar 10 vs. bar 4). Curcumin
pre-treatment had the same effect on c-Jun expression.
Although c-Jun levels in curcumin-pretreated UV-C
light exposed cells were 2.1, 1.5 and 1.2 times higher
compared to the control after 2, 4 and 24 h, respectively
(Fig. 2, bars 8, 9 and 10), they were remarkably reduced
compared to the cells untreated with curcumin before
radiation by 43, 78 and 71 %, respectively (Fig. 2, bar 8
vs. bar 2, bar 9 vs. bar 3, bar 10 vs. bar 4).
Effects of curcumin on galectin-3 and c-Jun
expression in cells exposed to MNNG
Alkylating agent MNNG provoked elevation of ga-
lectin-3 and c-Jun expression. Within first 4 h after addi-
tion of MNNG, galectin-3 amount increased for 54 %
compared to the controls (Fig. 3, bar 2) and stayed ele-
vated in the same range for the next 20 h of incubation
(Fig. 3, bar 6). Intensity of c-Jun elevation was in the ap-
proximately same range. Namely, after 4 h it reached
the level that was 63 % higher than the initial one (Fig. 4,
bar 2), and after 24 h it was slightly lower, but still 43 %
higher than in controls (Fig. 4, bar 6).
















4 h 24 h
Control M C C + M M C C + M
Time after adding of MNNG
Time after adding of MNNG
control cells MNNG (5 M)m curcumin (50 M)m curcumin (50 M) + MNNG (5 M)m m
4 h 24 h












Fig. 4. Effects of curcumin on basal and MNNG-induced expression of c-Jun.
A1235 glioblastoma cells were pre-incubated for 1 h in medium with or without curcumin (50mM), MNNG was or was not added to the
medium (to the final concentration of 5mM) and analyzed for c-Jun after 2, 4 and 24 h of further cultivation. Control cells were exposed
neither to curcumin nor to MNNG.
A. Western blot analysis of c-Jun. Cellular proteins (10 mg per lane) were separated by 12 % SDS-PAGE, transferred to Immobilon-P
membranes and analyzed with antibodies against c-Jun.
B. The amount of c-Jun was estimated by densitometric analysis and expressed as normalized values relative to the level of c-Jun in the
control cells. Average values (±SD) from two independent series of experiments (analyzed in duplicates) are shown.
* - p < 0.05 compared to the controls; ** - p < 0.05 compared to the corresponding curcumin-untreated cells
When cells were incubated with curcumin for 1 h
before exposure to MNNG, inducible effect of MNNG
on galectin-3 expression was slightly reduced after 4 h,
while after 24 h it was completely abolished. Namely, 4 h
after MNNG-exposure galectin-3 level in the curcumin-
-treated cells was 35 % higher compared to the control
(Fig. 3, bar 4), but after 24 h the significant difference
compared to the controls was not found (Fig. 3, bar 8).
However, the tendency of curcumin to suppress induc-
ible effect of MNNG on galectin-3 expression noticed af-
ter 4 h of incubation (Fig. 3, bar 4 vs. bar 2) became sta-
tistically significant after 24 h of incubation (Fig. 3, bar 8
vs. bar 6).
Curcumin had even stronger effect on c-Jun expres-
sion. Already after 4 h there was no statistically signifi-
cant difference between c-Jun level in the cells pretreat-
ed with curcumin before MNNG exposure and the
control level (Fig. 4, bar 4), while after 24 h c-Jun level
was reduced by 30 % compared to the control level (Fig.
4, bar 8). In comparison with the corresponding curcu-
min untreated cells, cells treaded with curcumin for 1 h
before MNNG exposure contained approximately 50 %
lower c-Jun amount after 4 and 24 h (Fig. 4, bar 4 com-
pared to bar 2, and bar 8 compared to bar 6).
Discussion
The induction of galectin-3 expression is tightly re-
lated to tumorigenicity and malignancy of many kinds
of neoplasms (8–10) at both the protein and the mRNA
levels. Conversely, the inhibition of galectin-3 expression
reduces tumor invasiveness and its metastatic potential
(11–13). Unraveling the interplay of the regulatory fac-
tors involved in galectin-3 expression is an important is-
sue (25–29) and biomedicine is highly interested in iden-
tifying likely inhibitors that restrain the process of ga-
lectin-3 expression.
It was shown that in the range of 20 to 200 mM con-
centrations curcumin, a natural, biologically active com-
pound extracted from turmeric, exhibits a broad spectrum
of beneficial biological effects, e.g. anti-inflammatory,
anti-mutagenic, anti-proliferative, and anti-cancerogenic
activities, without any toxic effect (30–32). Although the
complete genomic sequence of human galectin-3 gene
(LGALS3) has been reported, the regulation of LGALS3
expression is still largely unknown (33). Analysis of the
promotor region of LGALS3 revealed the existence of
multiple putative regulatory elements (e.g. Sp1, AP-1,
NF-kB and cAMP response element binding factor
(CREB)). Recently we have shown that the cell exposure
to alkylating agent MNNG as well as UV light (l=254
nm) induce galectin-3 expression and that both trans-
cription factors, Jun (AP-1) and NF-kB take part in the
regulatory mechanism of galectin-3 expression (21).
These findings, as well as the fact that c-Jun and NF-kB
activation can be inhibited by curcumin (18), encoura-
ged us to explore effects of curcumin on galectin-3 ex-
pression.
In this work we applied 50 mM concentration of
curcumin during 3, 5, and 25 h of incubation. Results
showed that it took 5 h of incubation in the presence of
curcumin until the decrease of galectin-3 level could be
seen. Prolonged incubation of 25 hours did not result in
further reduction of galectin-3 level, the 75 % of the con-
trol level, achieved after 5 h, was maintained. At the
same time c-Jun level, after reduction of 20 % after 5 h
continued to fall, and after 25 hours it reached 65 % of
the control value. In our earlier studies, Jun was recog-
nized as a regulator of the unstimulated expression of
galectin-3, since specific inhibition of jun by antisense-
-jun oligonucleotides significantly decreased basal levels
of galectin-3, while specific inhibitor of NF-kB, carboxy-
benzyl-leucyl-leucyl-leucine vinyl sulfone (zL3-vs) did
not show this effect (21). Taken together, these facts sug-
gest that curcumin affects galectin-3 expression in un-
stimulated cell through transcription factor AP-1, but
that some other transcription factor could also be in-
volved in this process, since the decrease of c-Jun level
was more pronounced than the decrease of galectin-3.
In this work, we have also shown that curcumin in-
hibited the elevation of galectin-3 level induced by UV-
-light radiation and alkylation agent MNNG. Curcumin
exerted more significant inhibitory effect when galec-
tin-3 expression was induced with MNNG than with
UV-C light. Namely, inducible effect of MNNG was
abolished after 24 h, while UV-light-provoked stimula-
tion was not fully eliminated. Similar result was obtai-
ned for c-Jun, but it is important to emphasize that UV-C
radiation provoked huge elevation of c-Jun level (6.7
times higher level comparing to the controls was de-
tected after 4 hours), while MNNG induced it mostly by
60 % compared to the controls. Such a huge elevation of
c-Jun level was not followed by a strong induction of
galectin-3. In our previous studies it was noticed that
when c-Jun expression was significantly suppressed by
antisense-jun oligonucleotides, there was still some in-
crease in galectin-3 after the exposure to UV-C light. It
was also shown that UV light-induced expression of ga-
lectin-3 related transcription factor NF-kB. Curcumin in-
hibits activation of both of these factors, hence uncom-
pleted suppression of UV light-induced expression of
galectin-3 achieved with curcumin suggests that some
other factors could be involved in this regulatory mech-
anism. On the other hand, inducible effect of MNNG on
galectin-3 expression was abolished with curcumin
treatment, so the central role in regulation of MNNG in-
duced expression of galectin-3 could be attributed to the
transcription factors c-Jun and NF-kB.
The key findings of this study include: (i) curcumin
(50 mM) was found to inhibit basal expression of galec-
tin-3 and c-Jun in human glioblastoma A1235 cells. (ii)
Cell pretreatment with curcumin (50 mM) for 1 h consid-
erably reduced UV-C light-induced expression of galec-
tin-3 and c-Jun. (iii) Cell pretreatment with curcumin (50
mM) for 1 h completely abolished MNNG-induced ex-
pression of galectin-3 and c-Jun. This study strongly sug-
gests that curcumin is a potent inhibitor of galectin-3 ex-
pression, and that it should be considered as a possible
drug for treatment of pathological conditions character-
ised by elevated expression of galectin-3.
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Kurkumin – sna`an inhibitor ekspresije galektina-3
Sa`etak
Galektin-3, lektin koji specifi~no prepoznaje b-galaktozidne strukture glikoproteina,
sudjeluje u razli~itim biolo{kim procesima. Patofiziolo{ka stanja i razli~iti uzro~nici stresa
bitno utje~u na ekspresiju galektina-3. Premda nisu poznati svi ~imbenici u regulacijskom
mehanizmu ekspresije galektina-3, pokazano je da u tom procesu sudjeluju transkripcijski
faktori AP-1 i NF-kB. Kurkumin, biolo{ki aktivan spoj izoliran iz biljnih podanaka vrste
Curcuma, interferira s djelovanjem obaju transkripcijskih faktora. Istra`ili smo u~inak kur-
kumina na ekspresiju galektina-3 u stanicama glioblastoma u bazalnim uvjetima te u stre-
su koji je bio izazvan izlaganjem stanica alkiliraju}em agensu N-metil-N'-nitro-N-nitrozo-
gvanidinu (MNNG) i ultraljubi~astom C (UV-C) svjetlu. Razina galektina-3 odre|ena je
tehnikom western-blot uz uporabu monoklonskih protutijela M3/38. Utvr|eno je da kur-
kumin smanjuje bazalnu razinu galektina-3 te da predinkubacija stanica kurkuminom jako
smanjuje inducibilni u~inak UV-C zra~enja, a potpuno uklanja induktivni u~inak alkilira-
ju}eg agensa MNNG. Rezultati nedvojbeno pokazuju da je kurkumin sna`an inhibitor eks-
presije galektina-3.
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